Literature DB >> 30467676

Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β.

Yuko Yamauchi1, Tetsuya Okuyama1, Toshinari Ishii1, Tadayoshi Okumura2,3, Yukinobu Ikeya4, Mikio Nishizawa1.   

Abstract

Pruni Cortex is a herbal drug from the bark of the Japanese flowering cherries, Prunus jamasakura or Prunus verecunda, and is included in the traditional Japanese herbal (Kampo) formula Jumihaidokuto, which is administered orally to patients suffering from inflammatory skin diseases. The flavanones contained in Pruni Cortex (e.g., sakuranetin and naringenin) have potent anti-inflammatory, anti-allergic, and anti-microbial activities. Although the effects of Pruni Cortex on skin disease have been well studied, reports regarding its pharmacological effects on the liver are limited. In this study, we extracted the bark of Prunus jamasakura and purified it to isolate the pharmacologically active constituents by monitoring nitric oxide (NO) production in rat hepatocytes that were treated with the pro-inflammatory cytokine, interleukin (IL)-1β. Sakuranetin and (-)-naringenin, which were present in an ethyl acetate-soluble fraction of the bark extract, significantly inhibited NO induction and inducible nitric oxide synthase (iNOS) expression. These two flavanones decreased the expression of type 1 IL-1 receptor gene and phosphorylation of Akt, also known as protein kinase B, which is regulated by phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K). Furthermore, sakuranetin decreased the phosphorylation of the activator isoforms of CCAAT/enhancer-binding protein β (C/EBPβ), which synergistically activates the transcription of the iNOS gene with nuclear factor κB (NF-κB). Therefore, sakuranetin inhibited the co-activating activity of C/EBPβ with NF-κB, leading to the suppression of iNOS gene expression in hepatocytes. Taken together, sakuranetin in Pruni Cortex downregulated the iNOS gene by inhibiting PI3K/Akt signal transduction and the phosphorylation of C/EBPβ. These results imply that sakuranetin may be primarily responsible for the anti-inflammatory effects of Pruni Cortex in the liver.

Entities:  

Keywords:  CCAAT/enhancer-binding protein β; Cherry bark; Interleukin 1 receptor; Kampo medicine; Nitric oxide; Nuclear factor κB

Mesh:

Substances:

Year:  2018        PMID: 30467676     DOI: 10.1007/s11418-018-1267-x

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  36 in total

Review 1.  The dual personality of NO.

Authors:  M Colasanti; H Suzuki
Journal:  Trends Pharmacol Sci       Date:  2000-07       Impact factor: 14.819

Review 2.  Regulation of the expression of inducible nitric oxide synthase.

Authors:  Hartmut Kleinert; Andrea Pautz; Katrin Linker; Petra M Schwarz
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

3.  Medical history: Seishu Hanaoka and his success in breast cancer surgery under general anesthesia two hundred years ago.

Authors:  Masaru Izuo
Journal:  Breast Cancer       Date:  2004       Impact factor: 4.239

4.  Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.

Authors:  Holger Buss; Anneke Dörrie; M Lienhard Schmitz; Elke Hoffmann; Klaus Resch; Michael Kracht
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

Review 5.  Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.

Authors:  N D Perkins
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

6.  Microbial transformation and bioactivation of isoflavones from Pueraria flowers by human intestinal bacterial strains.

Authors:  Ryota Tsuchihashi; Mitsuru Kodera; Seiichi Sakamoto; Yoshijiro Nakajima; Takashi Yamazaki; Yujiro Niiho; Toshihiro Nohara; Junei Kinjo
Journal:  J Nat Med       Date:  2009-02-14       Impact factor: 2.343

7.  Cytotoxic constituents from the bark of Salix hulteni.

Authors:  Seong Ho Jeon; Wanjoo Chun; Yong Joon Choi; Yong Soo Kwon
Journal:  Arch Pharm Res       Date:  2008-09-12       Impact factor: 4.946

8.  Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes.

Authors:  Kosuke Matsui; Mikio Nishizawa; Takashi Ozaki; Tominori Kimura; Iwao Hashimoto; Masanori Yamada; Masaki Kaibori; Yasuo Kamiyama; Seiji Ito; Tadayoshi Okumura
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 9.  Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health.

Authors:  Filippos Ververidis; Emmanouil Trantas; Carl Douglas; Guenter Vollmer; Georg Kretzschmar; Nickolas Panopoulos
Journal:  Biotechnol J       Date:  2007-10       Impact factor: 4.677

10.  Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes.

Authors:  Shigeru Teshima; Hideki Nakanishi; Mikio Nishizawa; Katsuhiko Kitagawa; Masaki Kaibori; Masanori Yamada; Kozo Habara; A-Hon Kwon; Yasuo Kamiyama; Seiji Ito; Tadayoshi Okumura
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

View more
  3 in total

1.  α-Glucosidase inhibitive diarylheptanoids from Ottelia acuminata var. acuminata, a traditional vegetable of Bai Nationality in Yunnan.

Authors:  Hong-Xing Liu; Jun-Zeng Ma; Yan-Song Ye; Jian-Jun Zhao; Shi-Jie Wan; Xin-Yue Hu; Gang Xu
Journal:  Nat Prod Bioprospect       Date:  2022-06-10

Review 2.  Stevia Genus: Phytochemistry and Biological Activities Update.

Authors:  Jimena Borgo; Laura C Laurella; Florencia Martini; Cesar A N Catalán; Valeria P Sülsen
Journal:  Molecules       Date:  2021-05-06       Impact factor: 4.411

Review 3.  A Review on Sources and Pharmacological Aspects of Sakuranetin.

Authors:  Monika Stompor
Journal:  Nutrients       Date:  2020-02-18       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.